Patent Assignment
Reel/Frame 030318/0978
Assignment of Assignor's Interest
Recorded: 2013-04-30
Pages: 4
Assignor
Assignee
ORPHAN DISEASE TREATMENT INSTITUTE CO., LTD.
1-2-58, HIROMACHI, SINAGAWA-KU, TOKYO, 140-8710, JAPAN
Covered Properties
(2)
Ena Nucleic Acid Drugs Modifying Splicing in Mrna Precursor
ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 13, 2005
From: MATSUO, MASAFUMI; TAKESHIMA, YASUHIRO; KOIZUMI, MAKOTO
To: MATSUO, MASAFUMI; TAKESHIMA, YASUHIRO; NONPROFIT ORGANIZATION TRANSLATIONAL RESEARCH ORGANIZATION OF DUCHENNE MUSCULAR DYSTROPHY
Reel/Frame 017354/0862 →
Assignment of Assignor's Interest
Aug 19, 2010
From: MATSUO, MASAFUMI; TAKESHIMA, YASUHIRO; NONPROFIT ORGANIZATION TRANSLATIONAL RESEARCH ORGANIZATION OF DUCHENNE MUSCULAR DYSTROPHY
To: KNC LABORATORIES CO., LTD. (25%)
Reel/Frame 024860/0598 →
Assignment of Assignor's Interest
Aug 21, 2012
From: KNC LABORATORIES CO., LTD.
To: DAIICHI SANKYO COMPANY, LIMITED
Reel/Frame 028819/0922 →
Assignment of Assignor's Interest
Apr 30, 2013
From: NONPROFIT ORGANIZATION TRANSLATIONAL RESEARCH ORGANIZATION OF DUCHENNE MUSCULAR DYSTROPHY
To: ORPHAN DISEASE TREATMENT INSTITUTE CO., LTD.
Reel/Frame 030319/0247 →
Individual Address Change
Jan 8, 2016
From: MATSUO, MASAFUMI; TAKESHIMA, YASUHIRO
To: MATSUO, MASAFUMI; TAKESHIMA, YASUHIRO
Reel/Frame 037459/0888 →
Assignment of Assignor's Interest
Aug 24, 2021
From: ORPHAN DISEASE TREATMENT INSTITUTE CO., LTD.
To: DAIICHI SANKYO COMPANY, LIMITED
Reel/Frame 057270/0430 →